Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Lorlatinib
Lorlatinib
1454846-35-5
|
406.155
|
1.865
Lorlatinib is a third-generation ALK tyrosine kinase receptor inhibitor. It is indicated for the treatment of adult patients with ALK-positive metastatic non-small cell lung cancer.
PF-06463922 | loratinib | lorlatinib
Lorlatinib is a third-generation ALK tyrosine kinase receptor inhibitor. It is indicated for the treatment of adult patients with ALK-positive metastatic non-small cell lung cancer.
PF-06463922 | loratinib | lorlatinib
$41/5 mg
(EBC)
1
CAS:1924207-18-0
0
We provide 0 compound for Lorlatinib